Nab-Paclitaxel in Metastatic Breast Cancer: Defining the Best Patient Profile

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|16|5|415-428

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.16, Iss.5, 2016-06, pp. : 415-428

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A randomized phase 2 study comparing EC or CMF versus nab-paclitaxel plus capecitabine as adjuvant chemotherapy for nonfrail elderly patients with moderate to high-risk early breast cancer (ICE II-GBG 52)

By von Minckwitz Gunter   Conrad Bettina   Reimer Toralf   Decker Thomas   Eidtmann Holger   Eiermann Wolfgang   Hackmann John   Möbus Volker   Marmé Frederik   Potenberg Jochem   Stickeler Elmar   Simon Eike   Thomssen Christoph   Huober Jens   Denkert Carsten   Alfer Joachim   Jackisch Christian   Nekljudova Valentina   Burchardi Nicole   Loibl Sibylle   von Minckwitz Gunter  

Cancer, Vol. 121, Iss. 20, 2015-10 ,pp. : 3639-3648

Blackwell Publishing

Access to resources Recommend Favorite

Albumin-Bound Paclitaxel: In Metastatic Breast Cancer

By Robinson Dean M.   Keating Gillian M.  

Drugs, Vol. 66, Iss. 7, 2006-01 ,pp. : 941-948

Adis International

Access to resources Recommend Favorite

Capecitabine plus paclitaxel in metastatic breast cancer

By  

Inpharma, Vol. 1, Iss. 1444, 2004-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Gemcitabine boosts paclitaxel efficacy in metastatic breast cancer

By  

Inpharma, Vol. 1, Iss. 1453, 2004-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

ABI 007 an advance on paclitaxel in metastatic breast cancer

By  

Inpharma, Vol. 1, Iss. 1423, 2004-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite